Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. DCTH
DCTH logo

DCTH

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DCTH News

Delcath Systems Reports Record Revenue and Growth in Q4 2025

Feb 26 2026seekingalpha

Delcath Systems Q4 Earnings Exceed Expectations

Feb 26 2026seekingalpha

Delcath Systems to Announce Q4 Earnings on February 26

Feb 25 2026seekingalpha

Delcath Systems to Host Q4 2025 Earnings Call on February 26, 2026

Feb 12 2026Newsfilter

Delcath Systems Reports Preliminary 2025 Revenue of $85.2 Million

Jan 09 2026Newsfilter

Three Microcap Companies Show Healthy Growth: OPXS, DCTH, MAMA

Jan 06 2026Benzinga

Delcath's HEPZATO KIT Shows Consistent Tumor Responses, Q3 Revenue Hits $19.3 Million

Jan 02 2026NASDAQ.COM

Delcath Publishes FOCUS Study Subgroup Analysis Results, Demonstrating Significant Efficacy

Dec 31 2025Newsfilter

Delcath Publishes 10-Year Study on Liver Cancer Treatment with 29.1 Months Survival Rate

Dec 03 2025Newsfilter

Are Options Traders Aware of Insights About Delcath Systems Stock That We Are Not?

Nov 24 2025NASDAQ.COM

Biotech Stocks Fluctuate Post-Market: Delcath Gains from Buyback, BioVie and Cassava Recover

Nov 21 2025NASDAQ.COM

Delcath Systems Reveals Release of Expert Review on Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases

Nov 18 2025Newsfilter

Delcath Systems Inc. Reports Decline in Q3 Earnings, Exceeding Expectations

Nov 04 2025NASDAQ.COM

Canaccord Genuity Reaffirms Buy Rating for Delcath Systems, Keeps $21 Price Target Intact

Oct 21 2025Benzinga

Delcath Shares Fall 5% Following Preliminary Q3 Results and Revised Full-Year Forecast

Oct 20 2025NASDAQ.COM

Delcath Systems announces $20.5M revenue for Q3 and revises FY revenue forecast downward.

Oct 20 2025SeekingAlpha